This is the authors' abstract. We don't add key points for this paper.
REVIEW QUESTION/OBJECTIVE: The objective of this systematic review is to assess the effectiveness of aggressive treatment of oligometastatic breast cancer (OMBC) on survival outcomes by conducting a meta-analysis of current available evidence.More specifically, the objectives are to identify the effectiveness of intensified multidisciplinary treatment with aggressive locoregional therapies on survival time, five-year survival rates and disease free survival. The population is adult women (18 years and over) with OMBC defined as single or few (five or less) metastases limited to a single organ and the comparative group is conventional palliative treatment aimed at disease control. Secondary objectives to be assessed will be adverse outcomes associated with intensified treatment regimes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Coombe et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: